Teva Pharmaceutical Industries
Israeli multinational pharmaceutical company specializing in generic medicines, specialty medicines, and active pharmaceutical ingredients.
Company Type
public
Founded
1901
Headquarters
Tel Aviv, Israel
Stock
NYSE: TEVA
About Teva Pharmaceutical Industries
Teva Pharmaceutical Industries operates as one of the world's largest generic pharmaceutical companies with operations in more than 60 countries. The company develops, manufactures, and markets generic medicines, specialty medicines, and active pharmaceutical ingredients.
The company's business model combines high-volume generic drug production with specialty pharmaceutical development. Teva generates revenue through generic drug sales, specialty medicines, and API sales to other pharmaceutical companies. The company is known for its expertise in developing complex generic formulations and biosimilar products.
Teva Pharmaceutical Industries employs approximately 37,000 people worldwide, with its headquarters in Tel Aviv, Israel, and major manufacturing and research facilities across North America, Europe, and Asia. The company continues to invest in research and development, complex generics, and specialty medicines.
History of Teva Pharmaceutical Industries
Teva Pharmaceutical Industries was founded in 1901 in Jerusalem as a small wholesale drug business by Yitzhak Elstein, Salomon Kahan, and Moshe Levinson. The company initially focused on importing and distributing medicines in Palestine under Ottoman rule.
Throughout the early 20th century, Teva expanded its operations and began manufacturing its own pharmaceutical products. The company played a significant role in providing medicines during World War II and the establishment of the State of Israel.
In the 1960s and 1970s, Teva began its international expansion, focusing on developing generic versions of off-patent medicines. The company went public on the Tel Aviv Stock Exchange in 1951 and later listed on the NASDAQ in 1987.
Throughout the 1980s and 1990s, Teva grew through strategic acquisitions, including the purchase of Lemmon Company in the United States (1985) and several European generic drug manufacturers. These acquisitions established Teva as a major player in the global generic pharmaceutical market.
In the 2000s and 2010s, Teva expanded into specialty medicines and biologics, developing innovative treatments for conditions like multiple sclerosis and migraine. The company acquired major pharmaceutical companies including Ivax Corporation (2005) and Actavis Generics (2016), further expanding its global presence.
Brands Owned by Teva Pharmaceutical Industries
Teva Pharmaceutical Industries owns 0 brands in our database.
Stock Information
Teva Pharmaceutical Industries Ownership: Pros & Cons
Advantages
- +Market leadership in generic pharmaceuticals with extensive portfolio
- +Strong manufacturing capabilities and global production network
- +Expertise in complex generic formulations and regulatory approvals
- +Diversified revenue streams from generics and specialty medicines
- +Established relationships with healthcare providers and payers worldwide
Considerations
- -Intense competition from other generic manufacturers and specialty pharmaceutical companies
- -Regulatory challenges and patent litigation in multiple markets
- -Dependence on patent expirations for generic drug opportunities
- -Pricing pressure from healthcare cost containment measures
- -Need to balance generic volume with specialty medicine development
Frequently Asked Questions About Teva Pharmaceutical Industries
Is Teva Pharmaceutical Industries owned by another company?
No, Teva Pharmaceutical Industries is an independent, publicly traded company with no parent organization. The company operates independently with shares traded on the New York Stock Exchange under the ticker symbol TEVA.
Is Teva Pharmaceutical Industries publicly traded?
Yes, Teva Pharmaceutical Industries is publicly traded on the New York Stock Exchange under ticker TEVA. The company has been publicly traded since its NASDAQ listing in 1987 and previously on the Tel Aviv Stock Exchange.
When was Teva Pharmaceutical Industries founded?
Teva Pharmaceutical Industries was founded in 1901 in Jerusalem as a wholesale drug business. The company has evolved from a small local distributor to one of the world's largest generic pharmaceutical manufacturers.
Who founded Teva Pharmaceutical Industries?
Teva Pharmaceutical Industries was founded by Yitzhak Elstein, Salomon Kahan, and Moshe Levinson in 1901. The founders established the company as a wholesale drug business that later evolved into pharmaceutical manufacturing.
What is Teva Pharmaceutical Industries' market position?
Teva Pharmaceutical Industries holds a leading position in the global generic pharmaceutical market and is one of the largest generic drug manufacturers worldwide. The company competes with other major generic manufacturers while expanding into specialty medicines and complex generics.
Jobs at Teva Pharmaceutical Industries
Latest News About Teva Pharmaceutical Industries
Related Articles About Teva Pharmaceutical Industries
View more articles
News & Updates
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
Who Brands StaffFeb 12, 2026
m-and-a-roundupacquisitionsnews
Industry Analysis
The Most Acquired Categories: Tech vs CPG vs Pharma
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.
Who Brands StaffFeb 11, 2026
acquisitionsindustry-analysistechnology
Consumer Education
The Truth About 'Made in America' Brand Claims
Many brands market themselves as American-made. But what does that actually mean when the parent company is foreign, the parts come from overseas, and 'assembled in USA' is not the same as 'made in USA'?
Who Brands StaffFeb 11, 2026
made-in-americaconsumer-educationbrand-claims